SCHEMBL26933828

SCHEMBL26933828

CC(C)(C)OC(=O)N1CCN(Cc2ccc(F)cc2)c2ccccc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 3/20 0.74
▸ HDAC6 Q9UBN7 3/20 0.74
▸ BRD4 O60885 3/20 0.54
▸ HDAC8 Q9BY41 1/20 0.43
▸ KDM1A O60341 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ DRD2 P14416 2/20 0.40
▸ DRD4 P21917 2/20 0.40
▸ SCN5A Q14524 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ EPHX2 P34913 1/20 0.40
▸ KCNT1 Q5JUK3 1/20 0.40
▸ BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31631234 1.00 HDAC1 (0.74) HDAC1HDAC6BRD4HDAC8KDM1A
SCHEMBL19225201 0.90 HDAC1 (0.77) HDAC1HDAC6BRD4HDAC8KDM1A
SCHEMBL26089401 0.89 HDAC1 (0.76) HDAC1HDAC6BRD4HDAC8KDM1A
SCHEMBL30910116 0.89 HDAC1 (0.76) HDAC1HDAC6BRD4HDAC8KDM1A
SCHEMBL31631249 0.87 HDAC1 (0.64) HDAC1HDAC6BRD4KDM1AKMT2A
SCHEMBL19278566 0.85 HDAC1 (1.00) HDAC1HDAC6BRD4HDAC8KDM1A
SCHEMBL26933848 0.83 HDAC1 (0.61) HDAC1HDAC6BRD4KDM1AKMT2A
SCHEMBL31631253 0.83 HDAC1 (0.61) HDAC1HDAC6BRD4KDM1AKMT2A
SCHEMBL31506844 0.83 HDAC1 (0.56) HDAC1HDAC6BRD4HDAC8MEN1
SCHEMBL30910107 0.83 HDAC1 (0.67) HDAC1HDAC6BRD4KDM1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4700021-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2026-02-25 — — EP disclosed
WO-2025127848-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2025-06-19 — — WO disclosed
EP-4538270-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT Sapiensbio Inc. (KR) 2025-04-16 — — EP disclosed
WO-2023239227-A1 NOVEL COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT 주식회사 사피엔스바이오 2023-12-14 — — WO disclosed
Send feedback